Item 9 Labs Corp
Change company Symbol lookup
Select an option...
INLB Item 9 Labs Corp
VMW VMware Inc
FORM FormFactor Inc
GLNG Golar LNG Ltd
DH Definitive Healthcare Corp
PLMIU Plum Acquisition I Corp
TSLA Tesla Inc
APCX AppTech Payments Corp
GP GreenPower Motor Company Inc
RIOT Riot Blockchain Inc
Go

Health Care : Pharmaceuticals |
Company profile

Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering products from its large-scale cultivation and production facilities in the United States. The Company produces cannabis and cannabis-related products and offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vape products as well as premium concentrates and Orion vape technologies. The Company's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The Company also offers a dispensary franchise model through the national Unity Rd. retail brand. Item 9 Labs cultivates elevated mainstream cannabis flower, vape cartridges, concentrates and Apollo & Orion vape technologies. The Company’s products are available to consumers through licensed dispensaries in Arizona. Its products are carried in more than 70 dispensaries throughout the state of Arizona.

Closing Price
$1.09
Day's Change
0.09 (9.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.09
Day's Low
0.90
Volume
(Heavy Day)
Volume:
25,505

10-day average volume:
14,741
25,505

Company Profile

Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering products from its large-scale cultivation and production facilities in the United States. The Company produces cannabis and cannabis-related products and offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vape products as well as premium concentrates and Orion vape technologies. The Company's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The Company also offers a dispensary franchise model through the national Unity Rd. retail brand. Item 9 Labs cultivates elevated mainstream cannabis flower, vape cartridges, concentrates and Apollo & Orion vape technologies. The Company’s products are available to consumers through licensed dispensaries in Arizona. Its products are carried in more than 70 dispensaries throughout the state of Arizona.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
3.87x
Price/Book (MRQ)
1.19x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

INLB is in a share class of common stock
Float
65.3M
Shares Outstanding
96.2M
Institutions Holding Shares
--
--

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Douglas BowdenChmn.
  • Andrew BowdenCEO
  • Robert E. MikkelsenCFO
  • Christopher WolvenCOO
  • Jeffrey I. RassasOther

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.